Denali Therapeutics Inc. DNLI Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s total debt?
- Denali Therapeutics Inc. (DNLI) reported total debt of $40.05M in Q1 2026.
- How has Denali Therapeutics Inc.'s total debt changed year-over-year?
- Denali Therapeutics Inc.'s total debt decreased by 22.3% year-over-year, from $51.57M to $40.05M.
- What is the long-term trend for Denali Therapeutics Inc.'s total debt?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s total debt has grown at a -9.3% compound annual growth rate (CAGR), from $68.87M to $42.37M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.